Timing of drotrecogin alfa (activated) treatment in severe sepsis

Crit Care. 2006;10(4):419; author reply 419. doi: 10.1186/cc5010.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug Administration Schedule
  • Humans
  • Protein C / administration & dosage*
  • Recombinant Proteins / administration & dosage
  • Sepsis / drug therapy*
  • Sepsis / microbiology
  • Systemic Inflammatory Response Syndrome / drug therapy
  • Systemic Inflammatory Response Syndrome / microbiology
  • Time Factors

Substances

  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated